Literature DB >> 8811359

Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.

V P Mursic1, G Wanner, S Reinhardt, B Wilske, U Busch, W Marget.   

Abstract

As clinical persistence of Borrelia burgdorferi in patients with active Lyme borreliosis occurs despite obviously adequate antibiotic therapy, in vitro investigations of morphological variants and atypical forms of B. burgdorferi were undertaken. In an attempt to learn more about the variation of B. burgdorferi and the role of atypical forms in Lyme borreliosis, borreliae isolated from antibiotically treated and untreated patients with the clinical diagnosis of definite and probable Lyme borreliosis and from patient specimens contaminated with bacteria were investigated. Furthermore, the degeneration of the isolates during exposure to penicillin G in vitro was analysed. Morphological analysis by darkfield microscopy and scanning electron microscopy revealed diverse alterations. Persisters isolated from a great number of patients (60-80%) after treatment with antibiotics had an atypical form. The morphological alterations in culture with penicillin G developed gradually and increased with duration of incubation. Pleomorphism, the presence of elongated forms and spherical structures, the inability of cells to replicate, the long period of adaptation to growth in MKP-medium and the mycoplasma-like colonies after growth in solid medium (PMR agar) suggest that B. burgdorferi produce spheroplast-L-form variants. With regard to the polyphasic course of Lyme borreliosis, these forms without cell walls can be a possible reason why Borrelia survive in the organism for a long time (probably with all beta-lactam antibiotics) [corrected] and the cell-wall-dependent antibody titers disappear and emerge after reversion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811359     DOI: 10.1007/bf01781096

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  38 in total

1.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  The recovery of L forms of Brucella and their relation to Brucella phage.

Authors:  E L NELSON; M J PICKETT
Journal:  J Infect Dis       Date:  1951 Nov-Dec       Impact factor: 5.226

3.  Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.

Authors:  J Schmidli; T Hunziker; P Moesli; U B Schaad
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

4.  Failure of tetracycline therapy in early Lyme disease.

Authors:  R J Dattwyler; J J Halperin
Journal:  Arthritis Rheum       Date:  1987-04

5.  Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi.

Authors:  A Kersten; C Poitschek; S Rauch; E Aberer
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

6.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

7.  Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.

Authors:  V Preac Mursic; W Marget; U Busch; D Pleterski Rigler; S Hagl
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

8.  An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Authors:  B Wilske; V Preac-Mursic; U B Göbel; B Graf; S Jauris; E Soutschek; E Schwab; G Zumstein
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis.

Authors:  T Häupl; G Hahn; M Rittig; A Krause; C Schoerner; U Schönherr; J R Kalden; G R Burmester
Journal:  Arthritis Rheum       Date:  1993-11

Review 10.  Lyme disease: an infectious and postinfectious syndrome.

Authors:  E S Asch; D I Bujak; M Weiss; M G Peterson; A Weinstein
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

View more
  26 in total

1.  Clinical findings associated with Borrelia burgdorferi infection in the dog.

Authors:  E Giudice; F Domina; D Britti; S Di Pietro; A Pugliese
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.

Authors:  S E Phillips; L H Mattman; D Hulínská; H Moayad
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 3.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 4.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

5.  Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

6.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Authors:  Øystein Brorson; Sverre-Henning Brorson; John Scythes; James MacAllister; Andrew Wier; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

7.  In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

Review 8.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

9.  Characterization of biofilm formation by Borrelia burgdorferi in vitro.

Authors:  Eva Sapi; Scott L Bastian; Cedric M Mpoy; Shernea Scott; Amy Rattelle; Namrata Pabbati; Akhila Poruri; Divya Burugu; Priyanka A S Theophilus; Truc V Pham; Akshita Datar; Navroop K Dhaliwal; Alan MacDonald; Michael J Rossi; Saion K Sinha; David F Luecke
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.